Home > Healthcare > Medical Devices > Therapeutic Devices > Membrane Oxygenators Market
The global membrane oxygenators market, valued at USD 132.1 million in 2024, is projected to grow at a CAGR of 2.2% from 2025 to 2034. The increasing prevalence of respiratory and cardiac disorders, including conditions like ARDS, cardiogenic shock, and myocarditis, drives the demand for advanced oxygenation systems, with membrane oxygenators being essential. Additionally, the growing geriatric population, more susceptible to these conditions, further boosts market growth. Technological advancements, such as hollow fiber membranes that improve gas exchange efficiency, also contribute to their expanding adoption in clinical settings.
Another driver is the growing utilization of extracorporeal membrane oxygenation (ECMO) therapy in critical care, particularly during emergencies like acute myocardial infarctions or post-transplant complications. The COVID-19 pandemic also highlighted the importance of membrane oxygenators in managing severe respiratory failure cases, significantly boosting market awareness and adoption.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Membrane Oxygenators Market Size in 2024: | USD 132.1 Million |
Forecast Period: | 2025 – 2034 |
Forecast Period 2025 – 2034 CAGR: | 2.2% |
2025 – 2034 Value Projection: | USD 162.8 Million |
Historical Data for: | 2021 – 2024 |
No. of Pages: | 140 |
Tables, Charts & Figures: | 134 |
Segments covered: | Type, Application, Age Group, End Use, Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Increased healthcare spending in developing nations, coupled with the expansion of advanced healthcare infrastructure, has further propelled market growth. Government initiatives to improve healthcare access and increasing training for ECMO deployment are also encouraging the use of membrane oxygenators.
Moreover, the development of portable and user-friendly systems is expanding the application of these devices in neonatal and pediatric care. With these innovations and an emphasis on improving patient outcomes, the membrane oxygenators industry is poised for substantial growth over the coming years.
Membrane oxygenators are medical devices used in extracorporeal life support to facilitate gas exchange by removing carbon dioxide and delivering oxygen to the blood. Utilizing advanced membrane technologies like hollow fibers or flat sheets, they are essential in managing respiratory and cardiac failures, especially during ECMO procedures and critical care interventions.